CClinicalTrials.gg
RecruitingNCT07196007Updated Mar 27, 2026

Leveraging Community-clinical Linkages to Address Unmet Social Needs for People With Diabetes

An interventional study of Community-Clinical Intervention in Diabetes and Diabetes Mellitus, sponsored by Mary Lacy. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-27.

Sponsored by Mary Lacy · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Started Mar 2026; still recruiting 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
12,000
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study is a hybrid type 2 design to evaluate the effectiveness and implementation of a community-clinical linkage intervention in primary clinics to address unmet social needs for patients with diabetes living in rural communities. The study will take place in two rural communities in Kentucky, one in eastern Kentucky and one in western Kentucky.

Read the detailed description

This study will convene clinical and community partners to complete a rapid process improvement workshop (RPIW) to co-create scalable strategies to address unmet social needs and to implement the developed strategy in primary care clinics in two rural communities in Kentucky. Results from the RPIW will be used to design an implementation template with specific implementation strategies tailored to each unique community-clinical linkage (CCL). While implementation strategies will be tailored to each CCL, the overarching intervention components for all CCL include: 1) patient navigators; 2) health information technology; and 3) quality improvement support to clinical and community partners. The finalized intervention will then be rolled out across partner clinics using a parallel-group cluster design that facilitates pragmatic randomization. The effect of the intervention on referrals will be assessed by comparing referrals between intervention and control clinics. Secondary effectiveness outcomes include status of social needs (improved or not), patient-reported quality of life, and diabetes control (A1c \< 9.0% controlled vs A1c =9% uncontrolled). To evaluate implementation outcomes, we will use a mixed methods approach to examine process factors that affect reach, acceptance, and fidelity of the CCL intervention. This approach allows us to examine which strategies can be replicated and scaled up for implementation in other communities.

02

Conditions studied

  • Diabetes
  • Diabetes Mellitus

Browse trials for

Keywords

  • Unmet social needs
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's planned enrollment of 12,000 is above the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Mary Lacy is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Clinic/Staff Inclusion Criteria:

  • staff at the intervention or comparison clinic

Participant Inclusion Criteria:

  • age 18 or older,
  • is a patient at the intervention or comparison clinic
  • diagnosed with diabetes

Clinic/Staff Exclusion Criteria:

  • staff not at the intervention or comparison clinic

Participant Exclusion Criteria:

  • being under the age of 18,
  • not a patient at the intervention or comparison clinic
  • not diagnosed with diabetes
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
12,000 participants (estimated)

Study arms

  • Experimental
    Usual Screening Patients with Diabetes for Unmet Social Needs Plus a Community-Clinical Intervention

    The intervention will be developed by community-clinical partners and then implemented in primary care clinics in two rural communities in Kentucky. Intervention components include patient navigation using a Community Health Worker (CHW), health information technology (HIT) and quality improvement (QI) support to both clinical and community partners. Patients who screen positive for unmet social needs will work with CHWs to be connected to community organizations. The HIT support component includes implementing the Kentucky Health Information Exchange referral communication tool between clinics and community organizations and using the Kynect resource directory to refer patients to location-specific social services and community resources. The QI component includes identifying a quality improvement team and site champion, one-on-one calls with a QI advisor, action periods to test QI strategies, and support to validate health outcomes and social needs screening data.

    Behavioral: Community-Clinical Intervention

  • No intervention
    Usual Care

    Clinics randomized to the control arm will receive usual care

Interventions

  • BehavioralCommunity-Clinical Intervention

    The intervention involves enhancing usual care for screening patients with diabetes for unmet social needs and referring those who screen positive to a Community Health Worker. Patients who screen positive for unmet social needs will work with CHWs to be connected to community organizations.

06

What researchers measure

Primary outcomes

  1. Number of participants screened for social needs

    Number of participants screened for social needs intervention compared to control

    Time frame: Baseline, month 6 and month 12

  2. Number of referrals to community based organization by primary care clinic

    Number of referrals to community based organization in intervention compared to control

    Time frame: Baseline, month 6 and month 12

Secondary outcomes

  1. Change in Status of social needs

    Change in status of social needs, answered by a yes/no question as to accessed or not. Social needs include food insecurity, housing instability, difficulty with utilities, transportation issues, and intimate partner violence. Data will be reported as aggregate across needs.

    Time frame: Baseline, month 6 and month 12

  2. Change in Patient-Reported Outcomes Measurement Information System (PROMIS) -29

    The PROMIS - 29 measures health-related quality of life across seven domains. Scores are standardized on a T-score metric, with a mean of 50 and a standard deviation of 10 in a referent population. A higher score means more of the concept being measured.

    Time frame: Baseline, month 6 and month 12

  3. Percent of participants with A1c greater than or equal to 9.0%

    Change in A1c level; Diabetes control (A1c \< 9.0% controlled vs A1c =9% uncontrolled) via Electronic Health Record extract

    Time frame: Baseline, month 6 and month 12

07

Study locations

1 of 1 sites recruiting
  • University of Kentucky
    Lexington, Kentucky 40506, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07196007
Lead sponsor
Mary Lacy
Collaborators
Centers for Disease Control and Prevention
Responsible party
Mary Lacy (Assistant Professor, University of Kentucky) — Sponsor-investigator
First posted
Sep 29, 2025
Start date
Mar 10, 2026
Primary completion
Mar 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Mar 27, 2026

Study contacts

Carol R White, MPH
Contact
crwhit3@uky.edu
859-562-2684
Mary Lacy Leigh, PhD
Contact
mary.lacy@uky.edu
Beth Lacy Leigh
principal investigator · University of Kentucky

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion